Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
Health Canada Patents
Patent Expiration Date : 2023-07-31
Date Granted : 2013-04-02
Brand Name : ADCETRIS
Patent Number : 2494105
Filing Date : 2003-07-31
Strength per Unit : 50 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2023-07-31
Date Granted : 2013-04-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-11-28
Date Granted : 2012-10-02
Brand Name : ADCETRIS
Patent Number : 2430135
Filing Date : 2001-11-28
Strength per Unit : 50 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2021-11-28
Date Granted : 2012-10-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-01-08
Date Granted : 2022-04-12
Brand Name : ADCETRIS
Patent Number : 3051090
Filing Date : 2010-01-08
Strength per Unit : 50 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2030-01-08
Date Granted : 2022-04-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
